| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327702 | Gynecologic Oncology | 2005 | 8 Pages |
Abstract
HSP90 inhibitors are effective cytotoxic agents in gynecologic cancer cells. Further testing in in vivo model systems is warranted, with the goal of eventual translation to clinical trials in gynecologic oncology patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Dana R. Gossett, Megan S. Bradley, Xiaohong Jin, Jiayuh Lin,